Trinity Pharmaceuticals

Trinity Pharmaceuticals is a successful chemical engineering company set up in the early eighties by Charles Buckley, Margaret Lewis and Kenneth Dawson and primarily bankrolled by Ralph Charlton who continued to have a guiding influence until around 2014 when he is known to have resigned.

Charles secretly developed a novel stable catalyst for the borane reduction of ketones while working for Symvatec, and between them the scientists had access to many other valuable industry secrets, getting the company off to a good start.